» Articles » PMID: 9815219

Enhancement of Pulmonary Clearance of Moraxella (Branhamella) Catarrhalis Following Immunization with Outer Membrane Protein CD in a Mouse Model

Overview
Journal J Infect Dis
Date 1998 Nov 17
PMID 9815219
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Moraxella (Branhamella) catarrhalis is an important human respiratory tract pathogen. Outer membrane protein (OMP) CD is highly conserved among strains and has characteristics that indicate it may be an effective vaccine antigen. This study investigated the effect of immunization with OMP CD on pulmonary clearance following intratracheal challenge of mice with M. catarrhalis. Two routes of immunization were studied: mucosal immunization (intra-Peyer's patch followed by intratracheal boost) and intramuscular immunization with OMP CD. Both resulted in enhanced pulmonary clearance of M. catarrhalis compared with sham-immunized controls. Immunization with OMP CD induced specific antibodies in serum and bronchoalveolar lavage fluid and induced a specific lymphocyte proliferative response in T cells from mesenteric lymph nodes from mice mucosally immunized with OMP CD. On the basis of these results, OMP CD should undergo continued testing to determine whether it will induce a protective immune response in humans.

Citing Articles

A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges.

Perez A, Murphy T Hum Vaccin Immunother. 2017; 13(10):2322-2331.

PMID: 28853985 PMC: 5647992. DOI: 10.1080/21645515.2017.1356951.


A Cation-Binding Surface Protein as a Vaccine Antigen To Prevent Moraxella catarrhalis Otitis Media and Infections in Chronic Obstructive Pulmonary Disease.

Murphy T, Brauer A, Johnson A, Wilding G, Koszelak-Rosenblum M, Malkowski M Clin Vaccine Immunol. 2017; 24(9).

PMID: 28659326 PMC: 5585693. DOI: 10.1128/CVI.00130-17.


Potential impact of a Moraxella catarrhalis vaccine in COPD.

Perez A, Murphy T Vaccine. 2017; 37(37):5551-5558.

PMID: 28185742 PMC: 5545157. DOI: 10.1016/j.vaccine.2016.12.066.


Vaccine targets against Moraxella catarrhalis.

Ren D, E Pichichero M Expert Opin Ther Targets. 2015; 20(1):19-33.

PMID: 26565427 PMC: 4720561. DOI: 10.1517/14728222.2015.1081686.


Use of the Chinchilla model to evaluate the vaccinogenic potential of the Moraxella catarrhalis filamentous hemagglutinin-like proteins MhaB1 and MhaB2.

Shaffer T, Balder R, Buskirk S, Hogan R, Lafontaine E PLoS One. 2013; 8(7):e67881.

PMID: 23844117 PMC: 3699455. DOI: 10.1371/journal.pone.0067881.